Building the National Database of Health Centred on the Individual: Administrative and Epidemiological Record Linkage - Brazil, 2000-2015 by Augusto Afonso Guerra Junior, Ramon Gonçalves Pereira, Eli Iola Gurgel, Mariangela Cherchiglia, Leonardo Vinicius Dias, Juliano Ávila, Núbia Santos, Afonso Reis, Francisco Assis Acurcio, Wagner Meira Junior

“…CONCLUSIONS The National Health Database Centered on Individual was generated and it will allow researchers to perform clinical, pharmacological, pharmacoeconomic, real world evidence and others researchers/studies. …”
Get full text

Farmacoepidemiologia e farmacoeconomia della terapia anti-ipertensiva: uno studio osservazionale della popolazione della Asl di Ravenna by Luca Degli Esposti, Alessandro Capone, Mirko Di Martino, Stefania Saragoni, Samuele Berlini, Pierluigi Russo, Ezio Degli Esposti

“…The aim of the paper was to perform a pharmacoepidemiological and pharmacoeconomic analysis of antihypertensive drug treatment. …”
Get full text

ANALISA KOMPARASI EFEKTIVITAS DAN BIAYA ANTARA MONOTERAPI CEFTRIAXONE I.V DAN CEFTRIAXONE I.V DITAMBAH CIPROFLOXACIN I.V SEBAGAI TERAPI EMPIRIS PNEUMONIA DI RUMAH SAKIT by , Afifah Machlaurin, , DR. Satibi, M.Si., Apt.

“…One of the most important treatment in pneumonia is antibiotic. we have to consider not only rationale antibiotic therapy but also the pharmacoeconomic of the treatment. Wide variations in antimicrobial prescribing practices exist in hospitalized pneumonia. …”

The burden of bites and stings management: Experience of an academic hospital in the Kingdom of Saudi Arabia by Anas Khan, Waad H. Al-Kathiri, Bander Balkhi, Osama Samrkandi, Mohammed S. Al-Khalifa, Yousef Asiri

Get full text

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries by Konstantin Tachkov, Antal Zemplenyi, Antal Zemplenyi, Maria Kamusheva, Maria Dimitrova, Pekka Siirtola, Johan Pontén, Bertalan Nemeth, Zoltan Kalo, Zoltan Kalo, Guenka Petrova

Get full text

The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy by Maurizio Muscaritoli, Lorenzo Pradelli, Orietta Zaniolo, Sergio Iannazzo, Mario Eandi

“…Here we present a pharmacoeconomic evaluation of alanyl-glutamine dipeptide in critically ill patients admitted to Italian Intensive Care Units (ICUs). …”
Get full text

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis by Roberta Gualtierotti, Francesca Ingegnoli, Luciana Scalone, Paolo Cortesi, Eleonora Bruschi, Maria Gerosa, Pier Luigi Meroni

“…We suggest the use of EQ-5D in systemic sclerosis patients as an HRQoL measure in clinical practice, in randomised clinical trials and/or in pharmacoeconomic evaluations. …”
Get full text

The Impact of RSV Hospitalization on Children’s Quality of Life by August Wrotek, Oliwia Wrotek, Teresa Jackowska

“…Conclusions: RSV contributes significantly to the utility deterioration and QALY loss in the case of RSV hospitalization, and the patient-reported data should be used in pharmacoeconomic assessments of the impact of RSV.…”
Get full text

Persistent Allergic Rhinitis and the XPERT Study by Anthi Rogkakou, MD, Elisa Villa, MD, Valentina Garelli, MD, G Walter Canonica, MD

“…As secondary endpoints, similar evaluations at 1 week and 3, 4, 5, and 6 months, summary scores for a general health status questionnaire (Medical Outcomes Survey Short Form 36), comorbidities, pharmacoeconomic and safety evaluations. Levocetirizine significantly improved both the RQLQ overall score and the T5SS from week 1 to 6 months (P < .001). …”
Get full text

Modern views on medical provision of patients with rare diseases of the circulatory system in Ukraine and the world by I. S. Datsenko, A. V. Kabachna, V. S. Hulpa

“…There is a need to review and create a pharmaceutical component of Unified clinical protocols for the treatment of most nosologies of this group of diseases in the context of pharmacoeconomic studies to establish the clinical efficiency and economic feasibility of the introduced drugs.…”
Get full text

Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms by Ramakrishnan K, Bond TC, Claxton A, Sood VC, Kootsikas M, Agnese W, Sibbel S

“…Further studies are needed to evaluate the current economic burden of pruritus in ESRD patients and create possible options for an improved pharmacoeconomic profile in this patient population.Keywords: pruritus, end-stage renal disease, hemodialysis, itchiness, patient reported outcomes…”
Get full text

Cost-effectiveness of SQ&reg; HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany by Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M

“…Standardized quality (SQ&reg;) house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is a sublingually administered allergy immunotherapy tablet for patients with persistent moderate to severe HDM allergic rhinitis despite use of allergy pharmacotherapy.Objective: To assess the cost-effectiveness of SQ HDM SLIT-tablet in Germany for patients suffering from HDM allergic rhinitis.Methods: A pharmacoeconomic analysis, based on data collected in a double-blinded, phase&nbsp;III randomized placebo-controlled trial (n=992), was undertaken to compare SQ HDM SLIT-tablet in addition to allergy pharmacotherapy to placebo plus allergy pharmacotherapy. …”
Get full text

Development and validation of a scale to measure patients&amp;rsquo; trust in pharmacists in Singapore by Xu-Hao Zhang, Jing Jin, Surachat Ngorsuraches, Shu-Chuen Li

“…Xu-Hao Zhang1, Jing Jin1, Surachat Ngorsuraches2, Shu-Chuen Li31Department of Pharmacy, National University of Singapore, Republic of Singapore; 2Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand; 3Discipline of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Newcastle, AustraliaObjective: To develop and validate a scale to measure patients&amp;rsquo; trust in pharmacists for use as an outcomes predictor in pharmacoeconomic and pharmaceutical care studies.Methods: Literature review, study team discussion and focus group discussions were conducted to generate items of a candidate version to be pilot-tested for content validity. …”
Get full text

Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study by Simona de Portu, Giacomo Carteni, Andrea Belisari

“…Aim: the objective of our study was to investigate the pharmacoeconomic impact in the Italian context of temsirolimus vs interferon alfa in patients with metastatic renal-cell carcinoma and a poor prognosis. …”
Get full text

Cost&ndash;consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context by Schinco P, Cultrera D, Valeri F, Borchiellini A, Mantuano M, Gorla F, Savarese A, Teruzzi C

“…As far as we are aware, to date there have been no pharmacoeconomic analyses in order to assess the economic impact of treatments for severe VWD. …”
Get full text

Pharmacotherapy of small cell lung cancer: Current state-of-the-art by Tatyana A. Berezhnova, Yelena A. Lunyova, Kseniya S. Dyadina, Vladimir A. Borisov

“…Chemotherapy of the pathology under study requires high costs; therefore, a pharmacoeconomical assessment of the prescription of chemotherapy for small cell lung cancer is necessary to compare the costs of treatment and its effectiveness…”
Get full text

Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients by Edward Y. Liu, Kenneth L. McCall, Brian J. Piper

“…State formularies and prescription drug list variation may contribute to the drug reimbursements in Medicaid, though further research is needed to identify the health policy or pharmacoeconomic origins of these disparities.…”
Get full text

Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition by Kostić Marina, Jovanović Snežana, Tomović Marina, Popović-Milenković Marija, Janković Slobodan M.

“…In order to start using expensive biologic medicines in patients in transitional countries, special strategy and pricing policy of international pharmaceutical companies are necessary, which would include calculation of prices of biologic medicines on the basis of local pharmacoeconomic studies. [Projekat Ministarstva nauke Republike Srbije, br. 175007]…”
Get full text

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes by Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL

“…Efficacy studies also generally show benefit of combination therapy for patients in World Health Organization functional class II, with a consistent decrease in hospitalization. Pharmacoeconomic studies are limited but indicate that increased pharmacy costs are at least partially offset by decreased health care utilization, particularly inpatient care. …”
Get full text

Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro by Dabanović Vera, Kostić Marina, Janković Slobodan

“…We constructed a Markov model to compare cost effectivenss of dutasteride and finasteride using data from the available pharmacoeconomic literature and data about socioeconomic sphere actual in Montenegro. …”
Get full text